Elsevier

Sleep Medicine

Volume 13, Issue 8, September 2012, Pages 1033-1038
Sleep Medicine

Original Article
Is portable monitoring accurate in the diagnosis of obstructive sleep apnea syndrome in chronic pulmonary obstructive disease?

https://doi.org/10.1016/j.sleep.2012.06.011Get rights and content

Abstract

Background

No scientific evidence supports the use of portable devices to diagnose obstructive sleep apnea syndrome (OSAS) in patients with co-morbities. Our aim was to evaluate the accuracy of a portable monitoring device (Stardust – STD) in the detection of patients with chronic obstructive pulmonary disease (COPD).

Methods

Patients with COPD and clinical suspicion of OSAS were recruited for a prospective randomized study. The STD was used on two different nights: (1) at home (STDHome) and (2) at the sleep laboratory simultaneous with polysomnography (PSG-STDLab).

Results

A total of 72 patients underwent the proposed recordings. Forty-six volunteers were excluded due to recording problems, and data from 26 subjects were analyzed. The mean age was (mean ± SD) 62.8 ± 8.5 years, 50% were male, and the mean forced expiratory volume in the first second was 55 ± 11%. Significant intraclass correlation was observed between apnea–hypopnea index (AHI)-PSG vs. AHI-STDLab (r = 0.61, p < 0.0001) and AHI-STDHome (r = 0.47, p < 0.007). Kappa analysis also showed a significant agreement for severe group.

Conclusion

Despite the agreement found in a small number of patients between AHI, a large number of failures in the recording limits the use of this portable device for the diagnosis of OSAS in patients with COPD.

Introduction

Obstructive sleep apnea syndrome (OSAS) affects 3–7% of the general population [1]. In a recent population study in São Paulo, Brazil, the prevalence of OSAS was 32.9%, more frequent in men, in age groups above 50 years, and in obese individuals [2].

The association of OSAS and lung diseases, especially chronic obstructive pulmonary disease (COPD), is called the overlap syndrome [3]. Patients affected with overlap syndrome have worse hypoxemia, poor sleep quality, higher risk of pulmonary hypertension in the long-term, and cor pulmonale, which consequently leads to bad prognosis [4], [5], [6]. Some studies have reported the prevalence of overlap syndrome to be between 11% and 22% [4], [5], [7].

Polysomnography (PSG) is considered the golden standard for the diagnosis of OSAS, but has a high-cost and technically complex approach. The use during sleep of portable cardio-respiratory monitoring equipment at home without supervision is an alternative for OSAS diagnosis in patients with high clinical susceptibility [8], [9], [10], [11]. Some studies showed that a specific type of portable monitoring equipment (Stardust II [STD]) was effective for diagnosing OSAS in patients with high clinical probability, and these studies observed a robust correlation, sensitivity, and specificity compared to PSG [10], [12]. A recent publication tested STD in patients with coronary syndrome, showing favorable results in the use of this device (92% sensitivity and 67% specificity) [13]. However, to date, there is not enough scientific evidence to indicate the use of portable devices for the diagnosis of OSAS in patients with co-morbidities, especially lung diseases [8].

Based on these data our goal was to evaluate the accuracy of the STD, compared to PSG, for the diagnosis of OSAS in patients with COPD with high clinical probability of overlap syndrome.

Section snippets

Participants

We selected consecutive patients of both genders, over 40 years of age from the pneumology outpatient clinic of UNIFESP. Patients had been diagnosed with COPD in GOLD’s stages II and III [14], were stable (no COPD exacerbation in the last three months), were using bronchodilators without a dose change during that period, and had symptoms suggestive of OSAS (loud snoring, reported breathing pauses during sleep, and excessive sleepiness). We excluded patients with other sleep-related disorders, a

Results

Seventy-two patients diagnosed with COPD and clinical suspicions of OSAS were recruited and underwent the two nights of the study. PSG was effective in 93% of patients, and portable recordings of 41 volunteers had poor recording quality and were excluded from the analysis. The remaining 26 patients presented good recordings and were included in the final analysis (Fig. 1).

Comparing the demographic, physical examination, gasometry, smoking habits, spirometry, and 6-min walking test data in the

Discussion

OSAS is often associated with COPD. Portable monitoring is validated for use in patients with high clinical probability of OSAS; however, there is no evidence to apply that reasoning in overlap syndrome. Our study found significant recording failures of respiratory events.

The loss rate was approximately 61% considering all recordings, 39% when the recordings were performed at home, and 22% in the laboratory. This loss was very high, and bigger than in the other studies for the diagnosis of OSAS

Conflict of interest

The ICMJE Uniform Disclosure Form for Potential Conflicts of Interest associated with this article can be viewed by clicking on the following link: http://dx.doi.org/10.1016/j.sleep.2012.06.011.

. ICMJE Form for Disclosure of Potential Conflicts of Interest form.

Acknowledgments

We would like to thank Laura Castro, MsC, and Altay Souza, Ph.D., for valuable suggestions and statistical analyses.

References (36)

  • J.M. Marin et al.

    Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome

    Am J Respir Crit Care Med

    (2010)
  • N.A. Collop et al.

    Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine

    J Clin Sleep Med

    (2007)
  • J.F.S.-S.R. Polese et al.

    Portable monitoring devices in the diagnosis of obstructive sleep apnea: current status, advantages, and limitations

    J Bras Pneumol

    (2010)
  • R. Santos-Silva et al.

    Validation of a portable monitoring system for the diagnosis of obstructive sleep apnea syndrome

    Sleep

    (2009)
  • S. Esnaola et al.

    Diagnostic accuracy of a portable recording device (MESAM IV) in suspected obstructive sleep apnoea

    Eur Respir J

    (1996)
  • N. de Jesus Danzi-Soares et al.

    Obstructive sleep apnea is common among patients referred for coronary artery bypass grafting and can be diagnosed by portable monitoring

    Coron Artery Dis

    (2012)
  • R.A. Pauwels et al.

    Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

    Am J Respir Crit Care Med

    (2001)
  • N.C. Netzer et al.

    Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome

    Ann Intern Med

    (1999)
  • Cited by (0)

    View full text